One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building ...

Researchers at Harvard Medical School have found that blocking the neuron-released peptide CGRP decreases pain sensitivity and reduces lesion size in endometriosis. Endometriosis is a painful, steroid ...

CGRP is a small protein that circulates at elevated levels during a migraine. People who have chronic migraine consistently have higher levels of CGRP in their system. It's believed that CGRP is ...

Pain-sensing nerves and immune cells work together to wreak havoc in endometriosis, a painful condition that affects an ...

It blocks the action of a protein called calcitonin gene-related peptide (CGRP). Ubrelvy acts rapidly, often within minutes to hours. Ubrelvy (ubrogepant) is approved for treating migraine with or ...

CGRP is a small snippet of protein made in various places in the body. A messenger molecule that normally clicks into another molecule, called a receptor, on a cell’s surface, CGRP can turn on ...

However, CGRP wasn't acting alone as the team found that the nuclear protein IL-33, typically known as an alarm signal ...

They work by blocking the receptor of the CGRP protein. This is found in nerves in the head and neck and is thought to cause inflammation and migraine pain. These drugs have fewer side effects ...

“If we can very specifically target this CGRP protein, then hopefully we can prevent the occurrence of migraines,” said Dr. David Kudrow, director of the Neurological Research Institute of ...